Benjamin Bogucki, MD
Dermatology · Columbus, OHNPI 1740438423
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,262 of the $13,780 with a category attached, or 89.0%. It is spread thinly across 35 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations.
Across 923 payments — averaging $14.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- UCB, Inc.$2K
- Johnson & Johnson$1K
- Pfizer$1K
- LEO Pharma Inc.$780
- Novartis$719
- plus $5K from 29 others
Across 196 payments — averaging $10,030 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- UCB SA$1M
- AbbVie$291K
- Janssen Research & Development, LLC$245K
- E.r. Squibb & Sons, L.L.C.$207K
- Sanofi US Services Inc.$56K
- Incyte Corporation$56K
- plus $75K from 3 others
What the payments were for
- Consulting fees$1,1809%
- Food & beverage$12,26289%
- Education$3382%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 220 | $2,319 |
| UCB, Inc. | 52 | $1,909 |
| Johnson & Johnson(3 entities) | 131 | $1,486 |
| Pfizer | 114 | $1,161 |
| LEO Pharma Inc. | 49 | $780 |
| Novartis | 48 | $719 |
| Sanofi | 32 | $641 |
| Amgen | 34 | $551 |
| E.r. Squibb & Sons, L.L.C. | 20 | $497 |
| Lilly USA, LLC | 30 | $496 |
| Galderma Laboratories, L.p. | 32 | $418 |
| Arcutis Biotherapeutics, Inc. | 29 | $403 |
| Prugen, Inc. Pharmaceuticals | 9 | $280 |
| Regeneron Healthcare Solutions, Inc. | 13 | $277 |
| Almirall LLC | 13 | $258 |
| Mayne Pharma Commercial LLC | 17 | $224 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 12 | $217 |
| Incyte Corporation | 9 | $196 |
| Strata Skin Sciences, Inc. | 7 | $186 |
| Bristol Myers Squibb | 11 | $147 |
| Genentech USA, Inc. | 8 | $143 |
| Merck | 6 | $105 |
| Sun Pharmaceutical Industries Inc. | 4 | $63 |
| Journey Medical Corporation | 8 | $62 |
| Dermavant Sciences, Inc. | 2 | $38 |
| VYNE Pharmaceuticals Inc. | 2 | $36 |
| Dermira, Inc. | 2 | $30 |
| Verrica Pharmaceuticals Inc. | 1 | $25 |
| Novum Pharma, LLC | 1 | $21 |
| Organon | 2 | $19 |
| Promius Pharma LLC | 1 | $19 |
| Aclaris Therapeutics, Inc. | 1 | $16 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $14 |
| EPI Health, LLC | 1 | $14 |
| Mylan Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,780 in reported general payments places this provider in the 85th percentile of 460 dermatology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 18 | $129,126 |
| Dupixent PenDupilumab | 19 | $101,988 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 60 | $5,173 |
| Metronidazole | 31 | $3,471 |
| Fluocinonide | 74 | $3,137 |
| Doxycycline Hyclate | 213 | $2,445 |
| Clobetasol Propionate | 61 | $2,427 |
| Triamcinolone Acetonide | 204 | $2,356 |
| Tacrolimus | 11 | $2,284 |
| Ketoconazole | 140 | $2,170 |
| Fluorouracil | 27 | $2,089 |
| Hydrocortisone | 134 | $1,551 |
| Tretinoin | 20 | $988 |
| Clindamycin Phosphate | 18 | $750 |
| Gentamicin Sulfate | 26 | $632 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Columbus
- Nicholas BennerColumbus$356K
- Stephanie FabbroColumbus$82K
- Shari Hicks-GrahamColumbus$68K
- Benjamin KaffenbergerColumbus$24K
- Gwyn LondereeColumbus$20K
- Matthew ZirwasBexley$3.3M
- George DrewMarion$1.9M
- Rocco SerraoDayton$1.7M
- James LibeccoFairlawn$1.1M
- Pranav ShethWest Chester$978K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.